Evidence map›Paper›PMID 38665395›Full record

ArticleInformation (Basel)2024

Data Augmentation with Cross-Modal Variational Autoencoders (DACMVA) for Cancer Survival Prediction.

Sara Rajaram, Cassie S Mitchell

Open access · goldAbstract read
In one paragraph

Article in Information (Basel), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sara RajaramLaboratory for Pathology Dynamics, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
Cassie S MitchellLaboratory for Pathology Dynamics, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.ORCID 0000-0002-5472-6355
Georgia Institute of Technology · US

Funding

Regulatory and Human Study Operations (RHSO) Core CU19AG065169 · NIA · UNIVERSITY OF ARIZONA · PI BRINTON, ROBERTA EILEEN · 2021 to 2025
$59.8M
Inflamm-aging of osteoprogenitor cells: A therapeutic target for improved bone healing - Resubmission - 1 - Revision - 3R01AG056169 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEUCHT, PHILIPP · 2018 to 2022
$2.4M
Inflamm-aging of osteoprogenitor cells: A therapeutic target for improved bone healingR56AG056169 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEUCHT, PHILIPP · 2023 to 2023
$347k
NIA NIH HHS R01 AG056169NIA NIH HHS R56 AG056169NIA NIH HHS U19 AG065169
6 · The paper itself

Abstract

The ability to translate Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs) into different modalities and data types is essential to improve Deep Learning (DL) for predictive medicine. This work presents DACMVA, a novel framework to conduct data augmentation in a cross-modal dataset by translating between modalities and oversampling imputations of missing data. DACMVA was inspired by previous work on the alignment of latent spaces in Autoencoders. DACMVA is a DL data augmentation pipeline that improves the performance in a downstream prediction task. The unique DACMVA framework leverages a cross-modal loss to improve the imputation quality and employs training strategies to enable regularized latent spaces. Oversampling of augmented data is integrated into the prediction training. It is empirically demonstrated that the new DACMVA framework is effective in the often-neglected scenario of DL training on tabular data with continuous labels. Specifically, DACMVA is applied towards cancer survival prediction on tabular gene expression data where there is a portion of missing data in a given modality. DACMVA significantly (

Indexed as

cancer survival predictiondata augmentationGenerative Adversarial NetworkVariational Autoencoder

Identifiers

PMID38665395
PMCPMC11044918
OpenAlexW4390059487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.